You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • OP0202 Cetrorelix, a gonadotropin-releasing hormone antagonist, significantly reduces TNF-alpha and demonstrates efficacy in patients with active rheumatoid arthritis: A proof-of-concept, double-blind randomised trial

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Oral Presentations
Abstract Session: Molecules – small and smart
OP0202 Cetrorelix, a gonadotropin-releasing hormone antagonist, significantly reduces TNF-alpha and demonstrates efficacy in patients with active rheumatoid arthritis: A proof-of-concept, double-blind randomised trial

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014400
Mar 2014600
Apr 2014500
May 2014100
Sep 2014500
Oct 2014501
Nov 2014400
Dec 2014100
Jan 2015100
Feb 2015400
Mar 2015200
Apr 2015501
May 2015101
Jul 2015300
Aug 2015300
Sep 2015900
Oct 2015400
Nov 2015600
Dec 2015200
Feb 2016200
Mar 2016400
Apr 2016801
May 2016500
Jun 2016300
Jul 2016400
Aug 2016400
Sep 2016502
Oct 2016400
Nov 20161101
Dec 2016900
Jan 2017701
Feb 20171300
Mar 2017500
Apr 2017600
May 2017100
Jun 2017300
Aug 2017600
Sep 20171400
Oct 2017400
Nov 2017600
Dec 20171000
Jan 2018800
Feb 20189803
Mar 20182401
Apr 20181800
May 20185801
Jun 20181800
Jul 20181400
Aug 20181000
Sep 2018200
Oct 2018800
Nov 20181000
Dec 2018400
Jan 2019400
Mar 2019400
Apr 2019200
May 2019400
Jun 2019200
Jul 2019300
Aug 2019400
Oct 2019601
Dec 20191001
Jan 2020200
May 20201000
Jun 20201200
Jul 20201200
Sep 20201001
Oct 20204800
Nov 2020401
Dec 2020400
Jan 2021400
Feb 2021800
Apr 2021400
Jun 2021300
Jul 2021100
Oct 2021800
Nov 2021201
Dec 2021200
Jan 2022200
Feb 2022200
Mar 2022800
Apr 2022200
May 2022600
Jun 2022200
Jul 20222400
Aug 20221300
Sep 20221400
Oct 2022200
Nov 20221000
Dec 2022800
Jan 2023200
Feb 2023600
Mar 2023200
Apr 20231000
May 2023200
Jul 2023400
Sep 2023600
Oct 2023300
Nov 2023600
Dec 2023800
Jan 2024600
Feb 2024600
Mar 2024200
Total806018